Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)
NCT01201057
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
132
Enrollment
INDUSTRY
Sponsor class
Conditions
Bacterial Vaginosis
Interventions
DRUG:
0.5% SPL7013 Gel
DRUG:
1.0% SPL7013 Gel
DRUG:
3.0% SPL7013 Gel
OTHER:
Placebo Gel
Sponsor
Starpharma Pty Ltd